Nicholson Meyer Capital Management’s AbbVie ABBV Stock Holding History

Nicholson Meyer Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$318K	Buy	1,214 +164	+16%	+$42K	0.19%	37
2026 Q2	$264K	Hold	1,050	–	–	0.18%	41
2026 Q1	$228K	Hold	1,050	–	–	0.18%	40
2025 Q4	$240K	Hold	1,050	–	–	0.18%	40
2025 Q3	$243K	Buy	+1,050	New	+$214K	0.19%	40
2025 Q2	–	Sell	-1,050	Closed	-$220K	–	46
2025 Q1	$220K	Buy	+1,050	New	+$204K	0.2%	43

Other funds holding ABBV

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Nicholson Meyer Capital Management's ABBV Position: Q3 2026 in Review

Nicholson Meyer Capital Management increased its AbbVie (ABBV) stake by 16% in Q3 2026, buying an estimated $42K and bringing the position to 1,214 shares worth $318K. The position accounts for 0.19% of the portfolio, ranked #37.

Nicholson Meyer Capital Management first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 3,450 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Nicholson Meyer Capital Management held 1,214 shares of AbbVie worth $318K as of Q3 2026.
Nicholson Meyer Capital Management bought 164 AbbVie shares in Q3 2026, an estimated $42K.
AbbVie made up 0.19% of Nicholson Meyer Capital Management's portfolio in Q3 2026, its #37 holding.
Nicholson Meyer Capital Management first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
3,450 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Nicholson Meyer Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.